Platelet-rich Plasma Intra-articular Knee Injections from Open Preparation Techniques Do Not Pose a Higher Risk of Joint Infection: A Systematic Review of 91 Randomized Controlled Trials and 5914 Injections

Overview

Journal J Exp Orthop

Publisher Wiley

Specialty Orthopedics

Date 2024 Sep 25

PMID 39318712

Authors

Mohammad Sami Alazzeh

Hamza Adnan Mohammad Naseh

Angelo Vasiliadis

Markus Laupheimer

Georgios Kalifis

Ayyoub Al-Dolaymi

Luca Macchiarola

Theodorakys Marin Fermin

Affiliations

Soon will be listed here.

Abstract

Purpose: To compare the infection rate of intraarticular platelet-rich plasma (PRP) knee injections between open and closed techniques in randomized controlled trials (RCTs) published in the last decade.

Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, PubMed, Scopus and Virtual Health Library were accessed in October 2022 using the terms 'platelet-rich plasma', 'PRP', 'knee' and 'tibiofemoral' alone and in combination with Boolean operators AND/OR. RCTs published during the last 10 years evaluating PRP intra-articular knee injections were considered eligible. Studies were excluded if the kit/preparation technique was not described. Data were presented using individual studies' absolute values, totals, and pooled percentages. Publication bias was assessed using the ROBIS tool.

Results: Ninety-one studies met the predetermined eligibility criteria. Forty-one implemented a closed technique, while 50 were open. All studies implementing a closed technique disclosed their commercial kits. Only 16 studies (17.58%) failed to report joint infections. Among the studies reporting joint infections as outcomes, 30 implemented a closed technique with 1195 patients, 1921 intra-articular knee injections and 95.44% of patient follow-up. On the other hand, 45 of them implemented an open technique with 2290 patients, 3993 intra-articular knee injections and 97.07% of patient follow-up. No patient had a joint infection among the included studies. Thirty-three studies prepared their PRP in controlled environments (36.26%). Most studies did not report where the preparation occurred (48.35%). Only twelve studies disclosed using laminar flow during preparation (13.19%). The infection rate for both techniques was 0 per 1000 knee injections.

Conclusion: Open PRP preparation techniques do not pose a higher risk of joint infection and can lower manufacturing costs when appropriate facilities are available. However, PRP preparation setting and laminar flow implementation data are deficient, and minimal requirements for good manufacturing practices demand further studies while adhering to local and regional regulations.

Level Of Evidence: Level I, systematic review of RCTs.

Citing Articles

The role of platelet-rich plasma in biomedicine: A comprehensive overview.

Zhang Z, Liu P, Xue X, Zhang Z, Wang L, Jiang Y iScience. 2025; 28(2):111705.

PMID: 39898035 PMC: 11787504. DOI: 10.1016/j.isci.2024.111705.

References

Dulic O, Rasovic P, Lalic I, Kecojevic V, Gavrilovic G, Abazovic D . Bone Marrow Aspirate Concentrate versus Platelet Rich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis. Medicina (Kaunas). 2021; 57(11). PMC: 8623697. DOI: 10.3390/medicina57111193. View

Ruane J, Ross A, Zigmont V, McClure D, Gascon G . A Single-Blinded Randomized Controlled Trial of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee with Active Control. J Stem Cells Regen Med. 2021; 17(1):3-17. PMC: 8372416. DOI: 10.46582/jsrm.1701002. View

Werner B, Cancienne J, Browning R, Verma N, Cole B . An Analysis of Current Treatment Trends in Platelet-Rich Plasma Therapy in the Medicare Database. Orthop J Sports Med. 2020; 8(2):2325967119900811. PMC: 7005975. DOI: 10.1177/2325967119900811. View

Machado E, Leite R, Dos Santos C, Artuso G, Gluszczak F, de Jesus L . Turn down - turn up: a simple and low-cost protocol for preparing platelet-rich plasma. Clinics (Sao Paulo). 2019; 74:e1132. PMC: 6691835. DOI: 10.6061/clinics/2019/e1132. View

Simental-Mendia M, Vilchez-Cavazos J, Pena-Martinez V, Said-Fernandez S, Lara-Arias J, Martinez-Rodriguez H . Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016; 136(12):1723-1732. DOI: 10.1007/s00402-016-2545-2. View

Kaminski R, Kulinski K, Kozar-Kaminska K, Wielgus M, Langner M, Wasko M . A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating Meniscal Healing, Clinical Outcomes, and Safety in Patients Undergoing Meniscal Repair of Unstable, Complete Vertical Meniscal Tears (Bucket Handle).... Biomed Res Int. 2018; 2018:9315815. PMC: 5866900. DOI: 10.1155/2018/9315815. View

Park Y, Kim J, Ha C, Lee D . Clinical Efficacy of Platelet-Rich Plasma Injection and Its Association With Growth Factors in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized Double-Blind Controlled Clinical Trial As Compared With Hyaluronic Acid. Am J Sports Med. 2021; 49(2):487-496. DOI: 10.1177/0363546520986867. View

Torrero J, Aroles F, Ferrer D . Treatment of knee chondropathy with platelet rich plasma. Preliminary results at 6 months of follow-up with only one injection. J Biol Regul Homeost Agents. 2013; 26(2 Suppl 1):71S-78S. View

Elik H, Dogu B, Yilmaz F, Akan Begoglu F, Kuran B . The efficiency of platelet-rich plasma treatment in patients with knee osteoarthritis. J Back Musculoskelet Rehabil. 2019; 33(1):127-138. DOI: 10.3233/BMR-181374. View

10.

Bastos R, Mathias M, Andrade R, Bastos R, Balduino A, Schott V . Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018; 26(11):3342-3350. DOI: 10.1007/s00167-018-4883-9. View

11.

Wu Y, Li T, Lee K, Lam K, Chang C, Chang C . Efficacy of a Novel Intra-Articular Administration of Platelet-Rich Plasma One-Week Prior to Hyaluronic Acid versus Platelet-Rich Plasma Alone in Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Controlled Trial. J Clin Med. 2022; 11(11). PMC: 9181501. DOI: 10.3390/jcm11113241. View

12.

Buendia-Lopez D, Medina-Quiros M, Fernandez-Villacanas Marin M . Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial. J Orthop Traumatol. 2018; 19(1):3. PMC: 6102156. DOI: 10.1186/s10195-018-0501-3. View

13.

Tucker J, Goetz L, Duncan M, Gilman J, Elmore L, Sell S . Randomized, Placebo-Controlled Analysis of the Knee Synovial Environment Following Platelet-Rich Plasma Treatment for Knee Osteoarthritis. PM R. 2021; 13(7):707-719. DOI: 10.1002/pmrj.12561. View

14.

Obana K, Schallmo M, Hong I, Ahmad C, Moorman 3rd C, Trofa D . Current Trends in Orthobiologics: An 11-Year Review of the Orthopaedic Literature. Am J Sports Med. 2021; 50(11):3121-3129. DOI: 10.1177/03635465211037343. View

15.

Angoorani H, Mazaherinezhad A, Marjomaki O, Younespour S . Treatment of knee osteoarthritis with platelet-rich plasma in comparison with transcutaneous electrical nerve stimulation plus exercise: a randomized clinical trial. Med J Islam Repub Iran. 2015; 29:223. PMC: 4606945. View

16.

Xu Z, He Z, Shu L, Li X, Ma M, Ye C . Intra-Articular Platelet-Rich Plasma Combined With Hyaluronic Acid Injection for Knee Osteoarthritis Is Superior to Platelet-Rich Plasma or Hyaluronic Acid Alone in Inhibiting Inflammation and Improving Pain and Function. Arthroscopy. 2020; 37(3):903-915. DOI: 10.1016/j.arthro.2020.10.013. View

17.

Alves R, Grimalt R . A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018; 4(1):18-24. PMC: 5806188. DOI: 10.1159/000477353. View

18.

Baria M, Pedroza A, Kaeding C, Durgam S, Duerr R, Flanigan D . Platelet-Rich Plasma Versus Microfragmented Adipose Tissue for Knee Osteoarthritis: A Randomized Controlled Trial. Orthop J Sports Med. 2022; 10(9):23259671221120678. PMC: 9486262. DOI: 10.1177/23259671221120678. View

19.

Di Martino A, Boffa A, Andriolo L, Romandini I, Altamura S, Cenacchi A . Leukocyte-Rich versus Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Trial. Am J Sports Med. 2022; 50(3):609-617. DOI: 10.1177/03635465211064303. View

20.

Fernandez-Fuertes J, Arias-Fernandez T, Acebes-Huerta A, Alvarez-Rico M, Gutierrez L . Clinical Response After Treatment of Knee Osteoarthritis With a Standardized, Closed-System, Low-Cost Platelet-Rich Plasma Product: 1-Year Outcomes. Orthop J Sports Med. 2022; 10(3):23259671221076496. PMC: 8977725. DOI: 10.1177/23259671221076496. View